Related Experiment Video
Updated: Aug 15, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Drug treatment of hypertension
1Department of Medicine and Therapeutics, University of Glasgow, Scotland, United Kingdom.
Insights
Effective hypertension drug treatments are available, but long-term benefits on mortality and coronary heart disease require further study. Individualized treatment plans consider patient factors for optimal blood pressure control.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Effective drug treatments for hypertension have advanced over the last 40 years.
- Newer antihypertensive medications offer improved efficacy, simpler dosing, and better patient acceptance.
- There is growing interest in the long-term effects of hypertension treatment on overall mortality and cardiovascular disease outcomes.
Purpose of the Study:
- To evaluate the long-term benefits of hypertension treatment, focusing on total mortality and morbidity.
- To assess the impact of various drug classes on coronary artery disease and its complications.
- To understand the evolving aims of hypertension management in the 1990s, emphasizing long-term outcomes.
Main Methods:
- Review of established and newer classes of antihypertensive drugs, including diuretics, beta blockers, ACE inhibitors, and calcium antagonists.
- Analysis of existing clinical data and experimental evidence regarding treatment effects on atherosclerosis and cardiovascular events.
- Examination of modified step-care approaches and individualized treatment strategies based on patient-specific factors.
Main Results:
- Established treatments (diuretics, beta blockers) effectively reduce stroke risk but show less impact on coronary heart disease than predicted.
- ACE inhibitors and calcium antagonists show potential for long-term influence on atherosclerosis, though objective clinical confirmation is pending.
- Current treatment aims focus on short-term blood pressure control and risk factor management to improve long-term outcomes.
Conclusions:
- Individualized hypertension treatment plans are crucial, selecting agents based on patient race, risk factors, and comorbidities.
- Further research is needed to objectively confirm the long-term benefits of newer drug classes like ACE inhibitors and calcium antagonists on atherosclerosis.
- The goal of hypertension management is to optimize short-term control for improved long-term patient prognosis and reduced cardiovascular morbidity and mortality.
Abstract:
Over the last 40 years effective drug treatment of hypertension has become available. Newer classes of drugs offer efficacy with simplicity of dosing regimen and good patient acceptability. However, there is increasing interest in the long-term benefits of treatment, particularly influences on total mortality and morbidity and mortality from coronary artery disease and its complications. Established treatments with diuretics and beta blockers do reduce stroke risk but have less than predicted effects on coronary heart disease. While there is experimental evidence and clinical pointers that ACE inhibitors and calcium antagonists may influence atherosclerosis in the long-term, there is as yet no objective clinical confirmation. The aim of treatment in the 1990s is to control blood pressure (and other risk factors) in the short-term with a view to improving long-term outcome. Many clinicians have modified step-care approaches to individualize drug treatment using one or two agents, selected from older and newer classes, which on clinical grounds are most appropriate in the individual patient. Factors determining choice are race, other risk factors and associated diseases.
More Related Videos
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Antihypertensive Drugs: Action of Diuretics
Antihypertensive Drugs: Vasodilators
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management

